Page 126 - NobleCon20-Book-Project

Health Care
Date November 21, 2024 Health Care
52wk High $9.60
52wk Low $2.22 Nutriband Inc. NTRB $4.98
121 South Orange Avenue
Orlando, FL 32801

(USD - in millions) www.nutriband.com
Market Cap 55.0
Enterprise 48.5
Basic Shares Out. 11.10 COMPANY OVERVIEW
Float 5.11
Institutional Holdings 2.51% Detailed Analysis:Channelchek.com
Short Interest 0.04
Avg. 90-Day Volume 0.03 We are primarily engaged in the development of a portfolio of
transdermal pharmaceutical products. Our lead product under
development is an abuse-deterrent fentanyl patch incorporating our
AVERSA™ abuse-deterrent technology. AVERSA™ technology can be
EPS Data incorporated into any transdermal patch to prevent the abuse, misuse,
diversion, and accidental exposure of drugs with abuse potential.
2022 2023 2024
CQ1 (0.08) N/A N/A
CQ2 (0.12) N/A N/A

CQ3 (0.14) N/A N/A
CQ4 (0.21) N/A N/A
CY (0.53) N/A N/A Source: Channelchek/QuoteMedia

Long-Term EPS Estimate N/A
Price/Book (mrq) 1.12
ROE (ttm) -74.87
Debt-to-Total Cap. (mrq) 1.69
Fiscal Year End 31-Jan

121 South OraOrlando FL 32801

Key Executives
CEO: Sheridan, Gareth
CFO: Goodman, Gerald
COO: Smith, Alan
IR: N/A
Noble Capital Markets, Inc.
Source: Capital IQ, Noble Financial estimates, company filings
Noble Senior Analyst 561-994-1191 noblecapitalmarkets.com
Robert LeBoyer MEMBERS: FINRA, SIPC, MSRB
Following the conference, complete video library of presentations will be
rleboyer@noblelsp.com available at: channelchek.com | nobleconference.com
(212) 896-4625

Refer to the back of the book for disclosures